Pregnancy outcomes in women with type 1 diabetes using insulin degludec.

"Declarations Conflict of interestERM have received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with preexisting diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation. Ethical standard statementThis study was in accordance with the Helsinki declaration. In addition, the study was approved by The National Committee on Health Research Ethics (H-15019186 and H-15009413) and The Danish Data Protection Agency (2012-58-0004, RH-2015-289, I-Suite: 04305). Informed consent disclosureAll participants gave written informed consent before the data collection. Conflict of interest ERM have received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with preexisting diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation."

"L. Ringholm has received a research grant from Novo Nordisk (Grant Number: U1111-1209-6358) for an investigator-sponsored study."